Hib Pro Vial Of 0.5ml Injection
Hib Pro 0.033 MG Description
Hib Pro injection contains Tetanus Toxoid, a bacterial vaccination. It protects against tetanus infection. Tetanus (also known as lockjaw) is a severe bacterial infection caused by the bacterium Clostridium tetani. It causes infected patients' jaw and neck muscles to lock up, making it difficult to open their mouths or swallow.
Tetanus toxoid vaccination protects against tetanus by generating a mild illness. It encourages our systems to create protective antibodies against the germs that cause tetanus. WHO recommends the tetanus vaccine as part of a childhood and adult vaccination plan. A booster dose of tetanus vaccine is typically required once every ten years to maintain protection. It can also be used after recent wounds or injuries that increase the chance of contracting tetanus infection.
Hib Pro injection cannot treat a current tetanus infection that has already occurred in the body. It can only be used to prevent disease before you are exposed to the vulnerable bacteria. If you have an acute infection or have previously been allergic to vaccinations or blood products, you should not get Hib Pro injection. Pregnant and breastfeeding women can use Hib Pro injection if their doctor prescribes it.
Hib Pro injection is generally safe and does not produce any adverse reactions. It may produce some modest adverse effects, such as discomfort and redness at the injection site or a low fever. These side effects are usually brief and disappear after a few days. However, if your symptoms increase, visit your doctor.
Product Summary
Offer Price | ₹408.61 |
You Save | |
Contains | Tetanus Toxoid(0.033 Mg) |
Uses | Prevention of Tetanus |
Side effects | Redness or pain at the injection site, fever |
Therapy | VACCINE |
Uses of Hib Pro 0.033 MG
Contraindications of Hib Pro 0.033 MG
- Hib Pro injection is not recommended if you have previously experienced anaphylaxis or any other serious allergic reaction to this vaccine, any other vaccine containing tetanus toxoid, or any of the components of this vaccine. ...
- Additionally, the vaccine should not be given to individuals who have a high fever or any other signs of acute illness.
Side effects of Hib Pro 0.033 MG
- Redness or pain at the injection site
- fever
Directions for Use of Hib Pro 0.033 MG
Quick Tips of Hib Pro 0.033 MG
- Tetanus vaccine protects against a potentially fatal bacterial infection causing muscle spasms.
- Immunity typically lasts 8-10 years, with boosters recommended to maintain protection.
- Children typically receive 5 doses of DTaP vaccine in their early years (covering tetanus, diphtheria, and pertussis).
- Boosters with Tdap are advised at age 11 and then every ten years throughout adulthood.
- Adults unvaccinated for tetanus may need a primary series of 3 shots.
- The vaccine is considered safe for most people, including pregnant women, and is highly effective.
- The cost of tetanus vaccination varies based on insurance and location but is generally affordable.
- Many clinics offer free or low-cost vaccination programs for those without insurance coverage.
- Tetanus vaccination can be administered safely alongside a COVID-19 vaccine with no need for waiting.
- The specific tetanus vaccine used depends on age and vaccination history; consult your doctor for advice.
- Pregnant women are particularly encouraged to get the tetanus vaccine to protect both themselves and their babies.
Storage and disposal of Hib Pro 0.033 MG
Dosage of Hib Pro 0.033 MG
Overdose
Mode of Action of Hib Pro 0.033 MG
How Does It Work?
Interactions of Hib Pro 0.033 MG
Interactions with other medicines
Content Details
Dr. Nikita Toshi
BDS (Bachelor of Dental Surgery)
Dr. Ritu Budania
MBBS, MD (Pharmacology)
Frequently Asked Questions (FAQs)
Q: What is the TT (Tetanus Toxoid) vaccine?
References
- Dano Vaccines and Biologicals Private Limited. [Accessed on 14 February 2024]
- Björkholm B, Hagberg L, Sundbeck G, Granström M. Booster effect of low doses of tetanus toxoid in elderly vaccinees. Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):195-9. doi: 10.1007/s100960050458
- Serum Institute of India Private Limited. Cyrus Poonawalla Group. [Accessed on 14 February 2024]